<DOC>
	<DOC>NCT01790958</DOC>
	<brief_summary>Microcurrent stimulation thereapy improves retinal efficiency and may restore and/or improve retinal function.</brief_summary>
	<brief_title>Microcurrent Stimulation to Treat Macular Degeneration</brief_title>
	<detailed_description>This is an observational study in which data will be collected from a group of patients with retinal diseases such as Dry Macular Degeneration, RetinitisPigmentosa, and Stargardt's Disease, who have opted to receive Microcurrent Stimulation Therapy as an alternative treatment for their retinal condition.</detailed_description>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Retinitis Pigmentosa</mesh_term>
	<mesh_term>Retinal Diseases</mesh_term>
	<criteria>Ability to provide written consent and comply with follow up visits Age 40 years or older ETDRS best corrected visual acuity better than 5 letters History of Dry Age Relted Macular Degeneration; Retinitis Pigmentosa; Stargardt's disease No AntiVEGF treatments for at least 3 months prior to study No new antioxidant/vitamin supplementation for at least 3 months prior to study History of NonCompliance with regular medical visits Significant media opacities (exclude NS 4+) that may interfere with assessing visual acuity Presence of pigment epithelial tears or rips Known serious allergies to fluorescein dye Presence of retinal neovascularization Any treatment with an investigation agent in the past 30 days</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>